Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR2 | O95136 | 6/20 | 0.75 |
| ▸ | S1PR1 | P21453 | 6/20 | 0.75 |
| ▸ | S1PR3 | Q99500 | 6/20 | 0.75 |
| ▸ | S1PR4 | O95977 | 5/20 | 0.75 |
| ▸ | TSHR | P16473 | 1/20 | 0.63 |
| ▸ | CETP | P11597 | 1/20 | 0.57 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.51 |
| ▸ | FDPS | P14324 | 2/20 | 0.51 |
| ▸ | ANPEP | P15144 | 1/20 | 0.50 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.50 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.50 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26908445 | 1.00 | S1PR2 (0.75) | S1PR2S1PR1S1PR3S1PR4TSHR | |
| SCHEMBL26908449 | 1.00 | S1PR2 (0.75) | S1PR2S1PR1S1PR3S1PR4TSHR | |
| SCHEMBL26908443 | 1.00 | S1PR2 (0.75) | S1PR2S1PR1S1PR3S1PR4TSHR | |
| SCHEMBL3208019 | 1.00 | S1PR2 (0.75) | S1PR2S1PR1S1PR3S1PR4TSHR | |
| SCHEMBL26908451 | 1.00 | S1PR2 (0.75) | S1PR2S1PR1S1PR3S1PR4TSHR | |
| SCHEMBL2399825 | 1.00 | S1PR2 (0.75) | S1PR2S1PR1S1PR3S1PR4TSHR | |
| SCHEMBL4414066 | 0.98 | S1PR2 (0.72) | S1PR2S1PR1S1PR3S1PR4TSHR | |
| Hydrochloric Acid SCHEMBL8729222 | 0.96 | S1PR2 (0.70) | S1PR2S1PR1S1PR3S1PR4TSHR | |
| SCHEMBL4406117 | 0.92 | S1PR2 (0.69) | S1PR2S1PR1S1PR3S1PR4TSHR | |
| SCHEMBL9414561 | 0.87 | S1PR2 (0.59) | S1PR2S1PR1S1PR3S1PR4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240116075-A1 | SUBSTRATE, SELECTIVE FILM DEPOSITION METHOD, DEPOSITION FILM OF ORGANIC MATTER, AND ORGANIC MATTER | CENTRAL GLASS COMPANY, LIMITED (JP) | 2024-04-11 | — | — | US | disclosed |
| EP-4287240-A1 | SUBSTRATE, SELECTIVE FILM DEPOSITION METHOD, DEPOSITION FILM OF ORGANIC MATTER, AND ORGANIC MATTER | Central Glass Company, Limited (JP) | 2023-12-06 | — | — | EP | disclosed |
| CN-116685715-A | Substrate, selective film deposition method, deposited film of organic substance, and organic substance | 中央硝子株式会社 | 2023-09-01 | — | — | CN | disclosed |
| CN-112778511-B | Catalyst composition for polyester production process | 科莱恩塑料和涂料有限公司 | 2023-03-28 | — | — | CN | disclosed |
| US-20220412963-A1 | FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES THROUGH REDUCTIVE AMINATION FOR ENHANCED MS SIGNALS | WATERS TECHNOLOGIES CORPORATION | 2022-12-29 | — | — | US | disclosed |
| WO-2022163825-A1 | SUBSTRATE, SELECTIVE FILM DEPOSITION METHOD, DEPOSITION FILM OF ORGANIC MATTER, AND ORGANIC MATTER | セントラル硝子株式会社 | 2022-08-04 | — | — | WO | disclosed |
| US-11353461-B2 | Methods of enhancing MS detection of tagged glycans | WATERS TECHNOLOGIES CORPORATION (US) | 2022-06-07 | — | — | US | disclosed |
| US-11352325-B2 | Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals | WATERS TECHNOLOGIES CORPORATION (US) | 2022-06-07 | — | — | US | disclosed |
| US-11061023-B2 | Fluorescence tagging of glycans and other biomolecules through reductive amination for enhanced MS signals | WATERS TECHNOLOGIES CORPORATION (US) | 2021-07-13 | — | — | US | disclosed |
| US-20190331669-A1 | FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES THROUGH REDUCTIVE AMINATION FOR ENHANCED MS SIGNALS | WATERS TECHNOLOGIES CORPORATION (US) | 2019-10-31 | — | — | US | disclosed |
| US-20190219587-A1 | METHODS OF ENHANCING MS DETECTION OF TAGGED GLYCANS | WATERS TECHNOLOGIES CORPORATION | 2019-07-18 | — | — | US | disclosed |
| CN-107075097-A | Catalyst composition for polyester production process | 科莱恩塑料和涂料有限公司 | 2017-08-18 | — | — | CN | disclosed |
| US-5574024-A | Methylene phosphonoalkylphosphinates, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism | EBETINO FRANK H (US) | 1996-11-12 | — | — | US | disclosed |
| EP-0298553-B1 | METHYLENE PHOSPHONOALKYLPHOSPHINATES, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR TREATING ABNORMAL CALCIUM AND PHOSPHATE METABOLISM | Norwich Eaton Pharmaceuticals, Inc. (US) | 1992-01-15 | — | — | EP | disclosed |
| EP-0298553-A1 | Methylene phosphonoalkylphosphinates, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism | Norwich Eaton Pharmaceuticals, Inc. (US) | 1989-01-11 | — | — | EP | disclosed |
| US-4602092-A | Method for making phosphinic acid intermediates | E. R. SQUIBB & SONS, INC. (US) | 1986-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11352325-B2 | Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals | FUT5, FUT6, ST3GAL3 | S1PR2 2121/4885S1PR1 1601/4885S1PR3 600/4885 |
| US-20190331669-A1 | FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES THROUGH REDUCTIVE AMINATION FOR ENHANCED MS SIGNALS | FUT5, FUT6, OGT | S1PR2 2642/4885S1PR1 2723/4885S1PR3 2204/4885 |
| US-20220412963-A1 | FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES THROUGH REDUCTIVE AMINATION FOR ENHANCED MS SIGNALS | FUT5, FUT6, OGT | S1PR2 2642/4885S1PR1 2723/4885S1PR3 2204/4885 |
| US-11061023-B2 | Fluorescence tagging of glycans and other biomolecules through reductive amination for enhanced MS signals | FUT5, FUT6, OGT | S1PR2 2642/4885S1PR1 2723/4885S1PR3 2204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.